Pediatric Vaccines: Global Markets

Oct 2022| PHM265A| BCC Publishing

Report Highlights

The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.

Report Includes

  • 21 data tables and 17 additional tables
  • A comprehensive overview of the current and future global markets for pediatric vaccines
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size for pediatric vaccines in USD million values, market forecast and corresponding market share analysis by technology, disease type (application), and geographic region
  • Highlights of the key growth driving factors and constraints that will shape the market for pediatric vaccines as the basis for projecting demand over the forecast period (2022-2027)
  • In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and other macroeconomics factors affecting the marketplace
  • Highlights of the COVID-19 impact on the global pediatric vaccines market, with pandemic implications on demand/supply of vaccines across the world, and govt. strategic decisions to boost the marketplace
  • Emphasis on the new developments in the pediatric vaccines market, and underlying clinical trials for all phases and list of vaccines
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Company profiles of major players within the industry, including Pfizer, Abbott Laboratories, Merck & Co., GlaxoSmithKline, Sanofi SA and AstraZeneca

Report Scope

This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market’s drivers, challenges and opportunities. The report also covers market projections through 2027 and estimates market shares for key players, as well as pediatric vaccines by type and by application. The report also discusses the impact of the COVID-19 pandemic on this market.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022–2027
Base year market size $32.2 billion
Market size forecast $50.2 billion
Growth rate CAGR of 7.8% from 2022 to 2027
Units considered $ Millions
Segments covered Technology, Disease Type, Region, Business Segment, Country
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Rest of Asia-Pacific
Key Market Drivers
  • Increasing Awareness and Government Support
  • Growing Investments and R&D
  • Product Approvals and Launches
  • Collaboration Agreements
  • Increasing Burden of Diseases
Companies studied
  • ABBOTT
  • ASTRAZENECA PLC
  • BHARAT BIOTECH INTERNATIONAL LTD.
  • CSL SEQIRUS UK LTD.
  • EMERGENT BIOSOLUTIONS INC.
  • GSK PLC.
  • MERCK & CO. INC.
  • PANACEA BIOTEC LTD.
  • PFIZER INC.
  • SANOFI
  • SERUM INSTITUTE OF INDIA PVT. LTD.
  • SINOVAC BIOTECH LTD.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Pediatric Vaccines: Global Markets110Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Technology Background18Free
Chapter- 4: Market Dynamics5Free
Chapter- 5: Impact of COVID-19 Pandemic2Free
Chapter- 6: Pediatric Vaccine Market, by Technology13Free
Chapter- 7: Pediatric Vaccine Market, by Disease Type15Free
Chapter- 8: Pediatric Vaccine Market, by Region20Free
Chapter- 9: New Developments2Free
Chapter- 10: Competitive Landscape2Free
Chapter- 11: Company Profiles25Free
Pediatric Vaccines: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS